诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVS 诺华

盘前交易 05-08 04:29:12 EDT

99.07

+1.34

+1.37%

盘前99.38

+0.31+0.31%

04:11 EDT

最高99.19	最低98.54	成交量115.98万
今开98.60	昨收97.73	日振幅0.67%
总市值2,021亿	流通市值1,937亿	总股本20.40亿
成交额1.15亿	换手率0.06%	流通股本19.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":99.07,"timestamp":1715112000000,"preClose":97.73,"halted":0,"volume":1159818,"hourTrading":{"tag":"盘前","latestPrice":99.38,"preClose":99.07,"latestTime":"04:11 EDT","volume":8,"amount":795.27,"timestamp":1715155895092},"delay":0,"floatShares":1955298792,"shares":2040406387,"eps":7.354219,"marketStatus":"盘前交易","marketStatusCode":1,"change":1.34,"latestTime":"05-08 04:29:12 EDT","open":98.6,"high":99.19,"low":98.54,"amount":114771455.688648,"amplitude":0.006651,"askPrice":99.32,"askSize":800,"bidPrice":99.26,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":7.354219,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715175000000},"adr":1,"adjPreClose":99.07,"adrRate":1,"dividendRate":0.039557,"preHourTrading":{"tag":"盘前","latestPrice":99.38,"preClose":99.07,"latestTime":"04:11 EDT","volume":8,"amount":795.27,"timestamp":1715155895092},"postHourTrading":{"tag":"盘后","latestPrice":98.86,"preClose":99.07,"latestTime":"19:50 EDT","volume":5170,"amount":512074.34,"timestamp":1715125851144},"volumeRatio":0.8830025335154709},"requestUrl":"/m/hq/s/NVS/","defaultTab":"news","newsList":[{"id":"2432602247","title":"更新版 1-由于需求稳定、价格上涨，Pop-Tarts 制造商凯兰诺华业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432602247","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432602247?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:08","pubTimestamp":1714658900,"startTime":"0","endTime":"0","summary":"Kellanova公司的产品组合多样化，包括Grahams饼干、Nutri-Grain早餐棒和Morningstar Farms等冷冻食品，加上溢价定价，帮助减轻了一些消费者转向低价替代品的影响。该公司表示，本季度价格上涨了 8.5%，而有机食品的销量却下降了 3.1%。该公司还拥有 Frosties 和 Special K 等国际知名麦片品牌，本季度调整后每股利润为 1.01 美元，超过预期的 85 美分。同行业的 Conagra Brands   也在上个月公布了乐观的季度业绩，这得益于其主食和冷冻食品需求的反弹 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431594928","title":"受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431594928","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431594928?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:21","pubTimestamp":1714393287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，德国生物技术公司Morphosys股价下滑，受到一则关于其药物或具有安全风险的新闻报道影响，但Morphosys表示，诺华制药对其收购仍有望在今年上半年完成。Pelabresib被视为Morphosys公司最有前途的药物之一，也是诺华制药对该公司感兴趣的原因之一。Morphosys发言人补充道：“诺华的收购计划正在稳步推进。”诺华制药于今年2月达成协议，将以27亿欧元的价格收购Morphosys公司。截至发稿，Morphosys美股盘前下跌2.38%，诺华制药美股盘前上涨了0.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114925.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430261584","title":"诺华制药2024财年第一财季实现净利润26.88亿美元，同比增加17.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430261584","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430261584?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:09","pubTimestamp":1714028954,"startTime":"0","endTime":"0","summary":"3月31日，诺华制药公布财报，公告显示公司2024财年第一财季净利润为26.88亿美元，同比增加17.23%；其中营业收入为118.29亿美元，同比减少8.68%，每股基本收益为1.32美元。从资产负债表来看，诺华制药总负债545.78亿美元，其中短期债务85.64亿美元，资产负债比为1.73，流动比率为0.91。机构评级：截至2024年3月31日，当前有19家机构对诺华制药目标价做出预测，其中目标均价为110.01美元，其中最低目标价为81.24美元，最高目标价为130.70美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515092587adf730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042515092587adf730&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429312288","title":"隔夜美股全复盘(4.24)| 三大股指集体高收，英伟达涨近4%；特斯拉营收遇滑铁卢，意外宣布力推平价车型助推股价盘后一度涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429312288","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2429312288?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:02","pubTimestamp":1713916943,"startTime":"0","endTime":"0","summary":"三大股指集体高收，英伟达涨近4%；特斯拉营收遇滑铁卢，意外宣布力推平价车型助推股价盘后一度涨逾11%","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723110","is_publish_highlight":false,"gpt_icon":1},{"id":"2429411083","title":"欧股“十一罗汉”｜AI云概念股SAP收涨将近5.3%，阿斯麦控股涨2.6%，诺和诺德与诺华涨超1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429411083","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429411083?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:41","pubTimestamp":1713890504,"startTime":"0","endTime":"0","summary":"思爱普收涨5.27%，报174.860欧元，连续第二个交易日反弹，3月27日曾涨至184.48欧元创盘中历史最高。阿斯麦控股荷兰阿姆斯特丹股价收涨2.59%，报834.30欧元。诺和诺德哥本哈根股价收涨1.83%，报891.30。诺华制药收涨1.81%，罗氏控股收涨1.73%，LVMH集团收涨1.31%，赛诺菲收涨0.77%，葛兰素史克伦敦股价收涨0.70%，雀巢收涨0.45%，阿斯利康收涨0.16%，欧莱雅收跌0.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042400414587a6f2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042400414587a6f2aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113675","title":"诺华制药涨3.2% Q1业绩超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113675","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2429113675?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:09","pubTimestamp":1713881361,"startTime":"0","endTime":"0","summary":"专题：聚焦美股2024年第一季度财报\n诺华制药(NVS.US)涨3.22%，报98.18美元。诺华制药第一季度营收增长10%至118.3亿美元，好于预期的114.9亿美元；调整后营业利润增长16%至45.4亿美元，超过分析师平均预期的约43亿美元。展望未来，该公司预计2024年全年销售额将以高个位数至低十位数的百分比增长，高于此前预期的中个位数；核心营业利润将以低十位数至15%的速度增长，此前预期为以高个位数增长。\n\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"http://n.sinaimg.cn/spider20240423/615/w350h265/20240423/38f2-ebd43ea88685328389897e8b1337dff7.jpg","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/spider20240423/615/w350h265/20240423/38f2-ebd43ea88685328389897e8b1337dff7.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-04-23/doc-inasvrzs8716141.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429118699","title":"Novartis(NVS.US)：2024年Q1财报实现营收118.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118699","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429118699?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:46","pubTimestamp":1713879974,"startTime":"0","endTime":"0","summary":"Novartis(NVS.US)：2024年Q1财报实现营收118.29亿美元，前值为129.53亿美元，预期值为114.8亿美元；每股收益为1.80美元，前值为1.71美元，预期值为1.69美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232157198b4acd9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232157198b4acd9b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429399118","title":"快讯| 美股三大指数集体高开，道指涨0.37%，纳指涨0.45%。通用汽车开盘涨超5%，公司发布第一季度业绩超预期并上调全年业绩指引；诺华制药涨超4%，2024年第一季度营收增长10%至118.3亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429399118","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2429399118?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:30","pubTimestamp":1713879059,"startTime":"0","endTime":"0","summary":"美股三大指数集体高开，道指涨0.37%，纳指涨0.45%。通用汽车开盘涨超5%，公司发布第一季度业绩超预期并上调全年业绩指引；诺华制药涨超4%，2024年第一季度营收增长10%至118.3亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232047327a54e8be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232047327a54e8be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150229","title":"美股异动｜诺华制药盘前涨超5% Q1业绩超预期 上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150229","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429150229?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:12","pubTimestamp":1713859925,"startTime":"0","endTime":"0","summary":"诺华制药(NVS.US)美股盘前涨5.14%，报100美元。诺华制药第一季度营收增长10%至118.3亿美元，好于预期的114.9亿美元；调整后营业利润增长16%至45.4亿美元，超过分析师平均预期的约43亿美元。展望未来，该公司预计2024年全年销售额将以高个位数至低十位数的百分比增长，高于此前预期的中个位数；核心营业利润将以低十位数至15%的速度增长，此前预期为以高个位数增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316121187a52d48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316121187a52d48&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429815636","title":"诺华一季度业绩超预期，上调全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2429815636","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429815636?lang=zh_cn&edition=full","pubTime":"2024-04-23 14:34","pubTimestamp":1713854064,"startTime":"0","endTime":"0","summary":"第一季度营收增长10%，至118.3亿美元，好于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/dd63a69a6d8ade9aa741696feebde5bd","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/dd63a69a6d8ade9aa741696feebde5bd"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107404.html","is_publish_highlight":true,"gpt_icon":1},{"id":"2429613740","title":"诺华制药：Q1净销售额118.3亿美元，超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2429613740","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429613740?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:15","pubTimestamp":1713849331,"startTime":"0","endTime":"0","summary":"诺华制药(NVS.US)：第一季度净销售额118.3亿美元，市场预估114.9亿美元；上调全年净销售额和核心营业收入预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313153187a455f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313153187a455f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429132045","title":"诺华制药第一季度销售净额118.3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429132045","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2429132045?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:04","pubTimestamp":1713848666,"startTime":"0","endTime":"0","summary":"诺华制药第一季度销售净额118.3亿美元，市场预估114.9亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231304357a54bea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231304357a54bea9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427918017","title":"更新版 1-英国《金融时报》称，对冲基金 Shah Capital 促成诺华董事会改组","url":"https://stock-news.laohu8.com/highlight/detail?id=2427918017","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427918017?lang=zh_cn&edition=full","pubTime":"2024-04-15 12:45","pubTimestamp":1713156303,"startTime":"0","endTime":"0","summary":"     路透社4月15日 - 据英国《金融时报》周一报道，美国对冲基金Shah Capital周一致信Novavax   董事会，要求增加两名新的独立董事。英国《金融时报》援引一封信的内容报道，Shah Capital还希望这家生物技术公司调整其Covid-19疫苗的销售策略，该疫苗基于传统疫苗技术，主要针对因辉瑞公司和Moderna公司生产的mRNA疫苗出现罕见副作用而感到不安的老年人。Shah Capital 拥有 Novavax 6.7% 的股份。Shah Capital 和 Novavax 没有立即回应路透社的置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427601258","title":"据英国《金融时报》报道，对冲基金 Shah Capital 因 Covid 疫苗陷入困境而敦促诺华公司调整董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2427601258","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427601258?lang=zh_cn&edition=full","pubTime":"2024-04-15 12:12","pubTimestamp":1713154379,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月15日 - 据英国《金融时报》网站 (link) 报道，美国对冲基金 Shah Capital 周一致函 Novavax 董事会，要求增加两名新的独立董事。英国《金融时报》援引一封信的内容报道，Shah Capital还希望这家生物技术公司调整其Covid-19疫苗的销售策略，该疫苗基于传统疫苗技术，主要针对那些对辉瑞和Moderna公司生产的mRNA疫苗的罕见副作用感到不安的老年人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427642927","title":"隔夜美股全复盘(4.13)| 三大股指集体收跌，中东紧张局势加剧，叠加部分美国大型银行股财报喜忧参半，美股连续第二周收跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2427642927","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2427642927?lang=zh_cn&edition=full","pubTime":"2024-04-13 07:16","pubTimestamp":1712963782,"startTime":"0","endTime":"0","summary":"三大股指集体收跌，中东紧张局势加剧，叠加部分美国大型银行股财报喜忧参半，美股连续第二周收跌","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/718741","is_publish_highlight":false,"gpt_icon":0},{"id":"2426748249","title":"诺华(NVS.US)超10亿美元囊获Arvinas潜在“best-in-class”蛋白降解剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2426748249","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426748249?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:37","pubTimestamp":1712885866,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Arvinas宣布已与诺华达成独家战略许可协议。诺华将以高达10.1亿美元的款项获得Arvinas第二代雄激素受体靶向蛋白降解嵌合体ARV-766在全球范围内的开发和商业化权利。诺华同时获得Arvinas的另一款处于临床前阶段的AR靶向PROTAC降解剂AR-V7。Arvinas将获得总计1.5亿美元的预付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101492.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426253531","title":"诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426253531","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426253531?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:32","pubTimestamp":1712835152,"startTime":"0","endTime":"0","summary":"诺华制药已经对德国癌症制药商MorphoSys发起了收购要约，拟以每股68欧元或总计27亿欧元的现金收购该公司所有已发行股票。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240411/20240411193309_72568.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240411/20240411193309_72568.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101291.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426258783","title":"BUZZ-Arvinas 因与诺华达成前列腺癌药物许可协议而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2426258783","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426258783?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:31","pubTimestamp":1712835096,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月11日 - ** 药物开发商Arvinas   股价盘前上涨3.5%至38美元** 该公司与诺华  签订了 (link) 战略许可协议，在全球范围内开发和商业化其名为 ARV-766 的前列腺癌实验药物。** 根据协议，ARVN 将获得高达 10.1 亿美元的商业里程碑以及 ARV-766 的分级特许权使用费** 交易还包括向诺华公司购买公司临床前 AR-V7 项目的资产购买协议** ARVN 将获得 1.5 亿美元的预付款，用于 ARV-766 的许可和 AR-V7 项目的销售** 截至收盘，ARVN股价年累计下跌10.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426225836","title":"诺华公司以高达 10 亿美元的价格许可 Arvinas 公司生产抗癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2426225836","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426225836?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:17","pubTimestamp":1712834257,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月11日 - 瑞士制药商诺华公司（Novartis AG <NOVN.S)）周四表示，该公司已与美国药物开发商Arvinas <ARVN.O)达成了一项价值高达10.1亿美元的许可协议，以获得该公司的试验性前列腺癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":0.02},{"period":"1month","weight":0.0342},{"period":"3month","weight":-0.0424},{"period":"6month","weight":0.0626},{"period":"1year","weight":-0.0557},{"period":"ytd","weight":-0.0188}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日在瑞士成立。该公司提供满足全球患者和社会不断变化的需求的医疗保健解决方案。他们广泛的产品组合包括创新药物和肿瘤药物，仿制药和生物仿制药以及眼科护理设备。他们的使命是发现改善和延伸人们生活的新方法。他们的愿景是成为改变医学实践的值得信赖的领导者。他们的战略是利用科学的创新在不断增长的医疗领域提供更好的患者结果。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.014981},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.012188},{"month":3,"riseRate":0.5,"avgChangeRate":0.000575},{"month":4,"riseRate":0.708333,"avgChangeRate":0.018746},{"month":5,"riseRate":0.666667,"avgChangeRate":0.007063},{"month":6,"riseRate":0.541667,"avgChangeRate":0.009763},{"month":7,"riseRate":0.708333,"avgChangeRate":0.012897},{"month":8,"riseRate":0.375,"avgChangeRate":-0.006962},{"month":9,"riseRate":0.708333,"avgChangeRate":0.011946},{"month":10,"riseRate":0.458333,"avgChangeRate":-0.010373},{"month":11,"riseRate":0.625,"avgChangeRate":0.016564},{"month":12,"riseRate":0.708333,"avgChangeRate":0.0233}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}